Navigation Links
National Business Group on Health Elects Sally Welborn, Walmart Executive, to Board of Directors
Date:12/8/2009

WASHINGTON, Dec. 8 /PRNewswire/ -- The National Business Group on Health, a non-profit association of more than 280 mostly large employers, announced today that Sally Welborn, Senior Vice President of Benefits at Walmart, has been elected to its Board of Directors, effective immediately.

"We are thrilled to announce Sally's election to our Board of Directors," said Pamela Kimmet, Senior Vice President of Human Resources at Coca-Cola Enterprises Inc. and Chairman of the Business Group's Board of Directors. "Sally is a visionary leader and will add great personal and professional strength to our board, as well as insights and experiences in corporate human resources from the world's largest retailer."

Welborn is responsible for the design and administration of benefits including health care coverage and retirement plans for Walmart, the world's largest retailer. She has more than 25 years of experience in corporate human resources. Prior to joining Walmart, Welborn was Senior Vice President, Corporate Benefits, at Wells Fargo where she was responsible for the design and administration of all health and welfare and retirement programs.

Welborn is a graduate of the University of Texas at Arlington with a bachelor's degree in mathematics, and she has earned the Certified Employee Benefit Specialist Designation through the International Foundation of Employee Benefit Plans and the Wharton School of the University of Pennsylvania.

Helen Darling, President of the National Business Group on Health, said, "Sally has an outstanding career in corporate health benefits and human resources. Her leadership skills and experiences in policy affecting employers will be invaluable to our organization. We look forward to her many contributions."

About the National Business Group on Health

The National Business Group on Health is a non-profit membership organization of more than 280 members
'/>"/>

SOURCE National Business Group on Health
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... (PRWEB) September 18, 2014 It is almost ... sprint or walk for healthier and happier kids. The ... participate in the 4th Annual Miami Children’s Hospital 5K Run/Walk. ... http://www.hyundaihopeonwheels.org , The 5K will take place ... will be outside of Coral Gables City Hall located at ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Clinical trial ... data on the Edema clinical trial scenario. This report ... trials on Edema. It includes an overview of the ... site of trial conduction across the globe. The databook ... their phase, trial status, prominence of the sponsors and ...
(Date:9/18/2014)... PA (PRWEB) September 18, 2014 ... announces the launch of Good Neighbor Pharmacy University, ... access information that will educate and empower pharmacy ... “As the healthcare industry continues to evolve, Good ... as we deliver resources and tools to help ...
(Date:9/18/2014)... September 18, 2014 CD-adapco, the largest ... software, today announced its new partnership with Ben Ainslie ... CD-adapco simulation tool, STAR-CCM+® in the design of its ... participation in the 35th America’s Cup taking place in ... the America’s Cup is sustainability, the set of restrictive ...
(Date:9/18/2014)... more vegetables and drink less sugar, according to a ... it,s still not enough, the study goes on to ... comes to eating healthier at school , The research ... status, may inform a child,s diet. , The study ... education were 85 per cent more likely to eat ...
Breaking Medicine News(10 mins):Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 2Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 3Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 2Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 3Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 4Health News:Good Neighbor Pharmacy University Keeps Pharmacists Ahead of the Curve 2Health News:Ben Ainslie Racing Using STAR-CCM+ Simulation Software to Design 35th America’s Cup Racing Boat 2Health News:Kids eat better if their parents went to college 2
... a study published in the recent issue of Annals ... exercise //as preconditions to prevent and control diabetes type ... cost effective to control diabetes through rigorous exercise and ... diabetes reduces the body’s ability to store calories, resulting ...
... at the annual meeting of the American Academy of Orthopedic ... back pain may be the result of several problems other ... restrict the effect of a surgery. The study that had ... National Spine Network, US, said that patients who had other ...
... 100 patients at an ear , nose and throat clinic ... snoring // shouldn't expect to receive a diagnosis of obstructive ... examination alone instead an overnight sleep testing needs to be ... ,For the study, physicians evaluated the patients with a ...
... now that after delivery depressions, that had plagued new mothers all ... the delivery. As a result of this belief, many pregnant women ... new study that comes in the recent issue of British Medical ... to Deirdre Murphy of Dundee University, who had led the team ...
... twins and their mothers to see if there was a ... // of life and children's antisocial behavior by age 7 ... have increased problems with conduct and more antisocial behavior . ... the twins' birth and the likeliness of antisocial behavior in ...
... to treat agitation in patients with Alzheimer's or dementia, ... findings of a recent study .// ,For ... Twenty-six of the patients received quetiapine (an antipsychotic also ... also known as Exelon), and 29 received a placebo. ...
Cached Medicine News:
(Date:9/18/2014)... , Sept. 18, 2014 MiMedx Group, ... developer, processor and marketer of patent protected regenerative ... announced today that it has entered into a ... MiMedx will provide its dehydrated human amnion/chorion membrane ... non- exclusively on a private label basis. ...
(Date:9/18/2014)... 18, 2014  Halozyme Therapeutics, Inc. (NASDAQ: ... Food and Drug Administration (FDA) has removed the ... PEGPH20 in SWOG,s ongoing Phase 1b/2 clinical trial ... investigational drug PEGPH20 (PEGylated Recombinant Human Hyaluronidase) in ... with metastatic pancreatic adenocarcinoma.  The study will resume ...
(Date:9/18/2014)... -- Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company ... announced today that it has appointed Mr. Christopher ... of Clinical Development. During his extensive career ... successful global clinical operations teams, in the US and ... development of numerous therapeutics and diagnostics across a broad ...
Breaking Medicine Technology:MiMedx Signs Distribution Agreement With Zimmer 2MiMedx Signs Distribution Agreement With Zimmer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 2SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 4Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development 2
... (ASX: PGL; Nasdaq: PGLA) today announced additional,data from the ... this,year. This data was presented at the 58th Annual ... Diseases in Boston, USA(1). As the Phase 2 ... data analysis described in this presentation was performed to,evaluate ...
... overall rate of sustained virologic response in ... long-acting interferons in ... Albuferon non-responder study presented at the, Annual Meeting of the American Association for the Study ... ...
Cached Medicine Technology:Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 2Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 3Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 2Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 3Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 4Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 5Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 6
BioScrew® Bio-Absorbable Interference Screws and Delivery System Clinically equivalent to metal interference screws....
... Interference Screws. Optimal screw ... graft selection options. Robust ... deformation, and chamfered screw ... atraumatic tissue fixation. Features ...
Cannulated Interference Screws...
... on the TrueView II design, a new ... for small joint arthroscopy is available. The ... very durable thanks to Olympus advanced fibre ... class means bright images, brilliant colour reproduction, ...
Medicine Products: